(1) „Georges Gilles de la Tourette“. In: Wikipedia, Die freie Enzyklopädie.
Bearbeitungsstand: 3. September 2014, 11:49 UTC. URL:
https://de.wikipedia.org/w/index.php?title=Georges_Gilles_de_la_Tourette&oldid=13 3690643 (Abgerufen: 30. Dezember 2015, 13:26 UTC)
(2) Sprenger J. Der Hexenhammer. Darmstadt; 1974.
(3) Shapiro AK, Shapiro ES et al. Gilles de la Tourette Syndrom – Second Edition. 1988.
S.3f
(4) Shapiro AK, Shapiro ES et al. Gilles de la Tourette Syndrom – Second Edition. 1988.
S.6
(5) Shapiro AK, Shapiro ES et al. Gilles de la Tourette Syndrom – Second Edition. 1988.
S.7
(6) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition; 2013. p. 81-85.
(7) The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993 Oct;50(10):1013-1016.
(8) Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome.
Part 1: The epidemiological and prevalence studies. J Psychosom Res 2008;65(5):461-472.
(9) Knight TF, Steeves TF, Day LF, Lowerison MF, Jette NF, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012
Aug;47(2):77-90.
(10) Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: Selected findings from 3500 individuals in 22 countries. Dev Med Child Neurol 2000;42(7):436-447
(11) Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006 Jan;160(1):65-69.
(12) Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: A follow-up study. Ann Neurol 1987;22(3):383-385.
(13) Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an
epidemiological sample. J Am Acad Child Adolesc Psychiatry 2001;40(6):685-695.
(14) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; S.59
(15) Freeman RD, Tic disorders and ADHD: answers from a world.wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psych. 2007 Jun;16 Suppl 1:15-23.
(16) Woods DW, Himle MB, Miltenberger RG, Carr JE, Osmon DC, Karsten AM, Jostad C, Bosch A. Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder. J Abnorm Child Psychol. 2008 Feb;36(2):237-45.
(17) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; S.113-130.
(18) The Tourette Syndrome Association International Consortium for Genetics. A
complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 1999 Nov;65(5):1428-1436.
(19) Seuchter SA, Hebebrand J, Klug B, Knapp M, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, BAur MP. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genet Epidemiol 2000; 18:33-47.
(20) Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985; 42:652-658.
(21) Mathews CA; Bimson B, Lowe TL, Herrera LD, Budman CL, Erenberg G, Naarden A, Bruun RD, Freimer NB, Reus VI. Association between maternal smoking and increased symptom severity in Tourette_S syndrome. Am J Psychiatry 2006;
163:1066-1073.
(22) Pringsheim T, Sandor P, Lang A, Shah P, O’Connor P. Prenatal and perinatal morbiditiy in children with Tourette syndrome and attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2009 Apr;30(2):115-121.
(23) Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB.
Neurobiology and neuroimmunology of Tourette’s syndrome: an update. Cell Mol Life Sci 2004a; 61:886-898.
(24) Wendland JT, Grus FH, Hansen BH, Singer HS. Striatal antibodies in children with Tourette’s syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 2001; 119:106-113.
(25) Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg
Psychiatry 2003; 74:602-607.
(26) Hoekstra PJ, Horst G, Limburg PC, Troost PW, van Lang N, de Bildt A, Korf J, Kallenberg CG, Minderaa RB. Increased seroreactivity in tic disorder patients to 60 kDa protein band from a neuronal cell line. J Neuroimmunol 2003; 141:118-124.
(27) Rizzo R, Gulisano M, Pavone P, Fogliani F, Robertson MM. Increased
antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 2006; 21:747-753.
(28) Dale RC, Church AJ, Candler PM, Chapman M, Martino D, Giovannoni G. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls.
Neurology 2006; 66:1612.
(29) Martino D, Defazio G, Church AJ, dale RC, Giovannoni G, Robertson MM, Orth M.
Antineuronal antibody status and phenotype analysis in Tourette’s syndrome. Mov Disord 2007; 22:1424-1429.
(30) Martino D, Draganski B, Cavanna A, Church A, Defazio G, Robertson MM, Frackowiak RS, Giovannoni G, Critchley HD. Antibasal ganglia antibodies and Tourette’s syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population. J Neurol Neurosurg Psychiatry 2008; 79:820-822.
(31) Singer HS, Gause C, Morris C, Lopez P, Tourette Syndrome Study Group. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008;
121:1198-1205.
(32) Wenzel C, Wurster U, Müller-Vahl KR. Oligoclonal Bands in Cerebrospinal Fluid in Patients with Tourette’s Syndrome. Mov Disord 2011 Feb 1;26(2):343-346.
(33) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; S.113-130.
(34) Haugbøl S, Pinborg LH et al. Cerebral 5-HT2A receptor binding is increased in patients with Tourette’s syndrome. Int J Neuropsychopharmacol.. 2007
Apr;10(2):245-252.
(35) Gunther J, Tian Y, Stamova B et al. Catecholamine-related gene expression in blood correltaes with tic severity in tourette syndrome. Psychiatry Res. 2012 Dec 30;200(2-3):593-601.
(36) Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Understanding disability in Tourette syndrome. Dev Med Child Neurol 2009a; 51:468-472.
(37) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; p.131-178.
(38) Azrin NH, Nunn RG. Habit-reversal: a method of eliminating nervous habits and tics.
Behav Res Ther 1973; 11:619-628.
(39) Nunn RG, Azrin NH. Eliminating nail-biting by the habit reversal procedure. Behav Res Ther 1976; 14:65-67.
(40) Jacobson E. Progressive relaxation: a physiological and clinical investigation of muscular states and their significance in psychology and medical practice. Midway reprint ser. 1974.
(41) Wilhelm S, Petersin A.L. et al. Randomized Trial of Behavior Therapy for Adults with Tourette’s Disorder. Arch Gen Psychiatry. 2012 Aug; 69(8):795-803.
(42) Franklin SA, Walther MR, Woods DW. Behavioral interventions for tic disorders.
Psychiatr Clin North Am. 2010 Sep;33(3):641-655.
(43) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; p.174-178.
(44) Najib J. Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder. Adolesc Health Med Ther. 2012 May 8;3:51-66.
(45) Paszek J, Pollok B, Biermann-Ruben K, Müller-Vahl K, Roessner V, Thomalla G, et al. Is it a tic?--Twenty seconds to make a diagnosis. Mov Disord 2010 Jun
15;25(8):1106-1108.
(46) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; p.33-58.
(47) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; p.43-44.
(48) Freeman RD, Zinner SH, Müller-Vahl KR, Fast DK, Burd LJ, Kano Y, et al.
Coprophenomena in Tourette syndrome. Dev Med Child Neurol 2009 Mar;51(3):218-227.
(49) Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II:
pharmacological treatment. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96.
(50) Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res 2009;67(6):497-501.
(51) Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS.
Course of tic severity in Tourette Syndrome: the first two decades. Pediatrics 1998;
102:14-19.
(52) Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 2003 Oct 14;61(7):936-940.
(53) O'Connor K, Brisebois H, Brault M, Robillard S, Loiselle J. Behavioral activity associated with onset in chronic tic and habit disorder. Behav Res Ther 2003 Feb;41(2):241-249.
(54) Eapen V, Fox-Hiley P, Banerjee S, Robertson M. Clinical features and associated psychopathology in a Tourette syndrome cohort. Acta Neurol Scand 2004;109(4):255-260.
(55) Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993 Jan;150(1):98-102.
(56) Banaschewski T, Woerner W, Rothenberger A. Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol. 2003 Oct;45(10):700-703.
(57) Kurlan R, Lichter D, Hewitt D. Sensory tics in Tourette syndrome. Neurology 1989b;
39:731-734.
(58) Ganos C, Kahl U, Schunke O, Kühn S, Haggard P, Gerloff C, Roessner V, Thomalla G, Münchau A. Are premonitory urges a prerequisite of tic inhibition in Gilles de la Tourette syndrome? J Neurol Neurosurg Psychiatry, 2012 Oct;83(10):975-978.
(59) Woods DW, Himle MB, Miltenberger RG, Carr JE, Osmon DC, Karsten AM, et al.
Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder. J Abnorm Child Psychol 2008 Feb;36(2):237-245.
(60) Verdellen CW, Hoogduin CA, Keijsers GP. Tic suppression in the treatment of Tourette’s syndrome with exposure therapy: the rebound phenomenon reconsidered.
Mov Disord 2007 Aug 15; 22(11):1601-1606.
(61) Woods DW, Watson TS, Wolfe E, Twohig MP, Friman PC. Analyzing the influence of tic-related talk on vocal and motor tics in children with Tourette. J Appl Behav Anal. 2001 Fall;34(3):353-356.
(62) Himle MB, Woods DW. An experimental evaluation of tic suppression and the tic rebound. Behav Res Ther. 2005 Nov;43(11): 1443-1451.
(63) Achenbach, T. M. (1991). Manual for the child behavior checklist/4–18 and 1991 profile. Burlington: University of Vermont Press.
(64) Meidinger AL, Miltenberger RG, Himle M, Omvig M, Trainor C, Crosby R. An investigation of tic suppression and the rebound effect in Tourette’s disorder. Behav Modif. 2005 Sep;29(5):716-745.
(65) Goetz CG, Pappert EJ, Louis ED; Raman R, Leurgans S. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord. 1999 May;
14(3):502-506.
(66) Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989 Jul;28(4):566-573.
(67) Christiansen H, Kis B, Hirsch O, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Karemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Philipsen A. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensivity and specificity. Eur Psychiatry 2012 Jul;27(5):321-328.
(68) Conners CK, Erhardt D, Epstein JN, Parker J DA, Sitarenios G, Sparrow E. Self-Ratings of ADHD symptoms in adults I: Factor structure and normative data. J of Attention Disorders 1999 Oct; 3(3):141-151.
(69) Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rössler M.
Wender Utah rating scale. The short-version for the assessment oft he attention-deficit hyperactivity disorder in adults. Nervenarzt. 2002 Sep; 73(9):830-838.
(70) APA – American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders – DSM-IV-TR. 4th edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
(71) Walkup, JT; Rosenberg LA, Brown J, Singer HS. The validity of instruments
measuring tic severity in Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry.
1992 May;31(3):472-477.
(72) Woods DW, Piacentini J, Himle MB, Chang S. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination oft he premonitor urge
phenomenon in youths with Tics disorders. J Dev Behav Pediatr. 2005 Dec;26(6):397-403.
(73) Capriotti MR, Brandt BC, Ricketts EJ, Espil FM, Woods DW. Comparing the effects of differential reinforcement of other behavior and response-cost contigencies on tics in youth with Tourette syndrome. J Appl Behav Anal 2012;45:251-263.
(74) Woods DW, Himle MB. Creating tic suppression: comparing the effects of verbal instruction to differntial reinforcement. J Appl Behav Anal 2004;37:417-420.
(75) Marcks BA, Woods DW, Teng EJ, Twohing MP. What do those who know, know?
Investigating providers’ knowledge about Tourette’s Syndrome and its treatment. Cog Behav Practice 2004;11:298-305.
(76) Müller-Vahl K. Tourette-Syndrom und andere Tic-Erkrankungen – im Kindes- und Jugendalter. Berlin; 2010; p.35-37.
(77) Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndome. Neur 2003;61:936-940.